Cargando…
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
Chemotherapy-induced damage of hematopoietic stem and progenitor cells (HPSCs) often results in myelosuppression that adversely affects patient health and quality of life. Currently, chemotherapy-induced myelosuppression is managed with chemotherapy dose delays/reductions and lineage-specific suppor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299941/ https://www.ncbi.nlm.nih.gov/pubmed/34307165 http://dx.doi.org/10.3389/fonc.2021.697908 |